Intellectus Partners’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-32,298
| Closed | -$10.7K | – | 303 |
|
|
2025
Q4 | $10.7K | Buy |
32,298
+5,902
| +22% | +$1.29K | ﹤0.01% | 283 |
|
|
2025
Q3 | $5.33K | Buy |
26,396
+4,000
| +18% | +$840 | ﹤0.01% | 276 |
|
|
2025
Q2 | $6.04K | Hold |
22,396
| – | – | ﹤0.01% | 276 |
|
|
2025
Q1 | $4.42K | Hold |
22,396
| – | – | ﹤0.01% | 270 |
|
|
2024
Q4 | $5.15K | Hold |
22,396
| – | – | ﹤0.01% | 274 |
|
|
2024
Q3 | $2.19K | Buy |
+22,396
| New | +$3.92K | ﹤0.01% | 267 |
|
|
2024
Q2 | – | Sell |
-20,895
| Closed | -$6.32K | – | 271 |
|
|
2024
Q1 | $6.32K | Buy |
+20,895
| New | +$2.49K | ﹤0.01% | 261 |
|
|
2023
Q4 | – | Sell |
-13,891
| Closed | -$1.39K | – | 258 |
|
|
2023
Q3 | $1.39K | Buy |
13,891
+3,000
| +28% | +$400 | ﹤0.01% | 258 |
|
|
2023
Q2 | $1.8K | Buy |
+10,891
| New | +$1.7K | ﹤0.01% | 263 |
|
|
2023
Q1 | – | Sell |
-12,972
| Closed | -$1.87K | – | 267 |
|
|
2022
Q4 | $1.87K | Sell |
12,972
-7,037
| -35% | -$940 | ﹤0.01% | 262 |
|
|
2022
Q3 | $3K | Sell |
20,009
-1,699
| -8% | -$486 | ﹤0.01% | 262 |
|
|
2022
Q2 | $6K | Sell |
21,708
-1,875
| -8% | -$1.21K | ﹤0.01% | 252 |
|
|
2022
Q1 | $18K | Sell |
23,583
-1,166
| -5% | -$1.17K | 0.01% | 232 |
|
|
2021
Q4 | $47K | Sell |
24,749
-1,332
| -5% | -$3.02K | 0.01% | 265 |
|
|
2021
Q3 | $66K | Sell |
26,081
-333
| -1% | -$780 | 0.02% | 268 |
|
|
2021
Q2 | $69K | Buy |
+26,414
| New | +$86.1K | 0.02% | 264 |
|
Intellectus Partners's NUVB.WS Position: Q1 2026 in Review
Intellectus Partners sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 32,298 shares — an estimated $10.7K sold.
Intellectus Partners first reported a position in NUVB.WS in Q2 2021 and held it in 16 quarters. The position peaked at $69K in Q2 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Intellectus Partners reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Intellectus Partners sold 32,298 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $10.7K.
- Intellectus Partners first reported a position in Nuvation Bio Inc Warrants in Q2 2021 and held it in 16 quarters.
- Intellectus Partners's Nuvation Bio Inc Warrants position peaked at $69K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Intellectus Partners's 13F filing for Q1 2026, filed 10 Apr 2026.